CBB
PTCT icon

Citizens Business Bank’s PTC Therapeutics PTCT Stock Holding History

Citizens Business Bank’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,300
Closed -$211K – 255
2021
Q4 		$211K Buy
+5,300
New +$203K 0.03% 242

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Citizens Business Bank's PTCT Position: Q1 2022 in Review

Citizens Business Bank sold out of PTC Therapeutics (PTCT) in Q1 2022, closing a stake of 5,300 shares — an estimated $211K sold.

Citizens Business Bank first reported a position in PTCT in Q4 2021 and held it in 1 quarter. The position peaked at $211K in Q4 2021. 183 funds tracked by Wall St. Rank hold PTCT as of Q1 2022.

  • Citizens Business Bank reported no remaining PTC Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Citizens Business Bank sold 5,300 PTC Therapeutics shares in Q1 2022, an estimated $211K.
  • Citizens Business Bank first reported a position in PTC Therapeutics in Q4 2021 and held it in 1 quarter.
  • Citizens Business Bank's PTC Therapeutics position peaked at $211K in Q4 2021.
  • 183 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2022.

Based on Citizens Business Bank's 13F filing for Q1 2022, filed 18 Nov 2022.